Dr. Rejish K. Thomas

* 1. The session met the stated learning objectives

  1 Learning objective not met 2 3 Learning objective partially met 4 5 Learning objective met
Learning Objective 1:  To present findings from a local, retrospective, open label, database study on intravenous ketamine for ultraresistant depression
Learning Objective 2: To investigate the response rate of intravenous ketamine and clinical predictors of effectiveness in this study and in the literature
Learning Objective 3: To discuss future directions in clinical and in research settings for ketamine as an antidepressant

* 2. On a scale from 1 (not at all relevant) to 5 (extremely relevant), please rate how relevant this presentation is to you. By relevance, we mean how appropriate the topic and effective the speaker is for you.

* 3. On a scale from 1 (no opportunity) to 5 (outstanding opportunity for discussion and interaction), please rate how interactive this presentation was for you.  By interaction we mean discussion, questions and engagement with the presenter and the topic.

* 4. Please provide us with any additional comments or observations you would like us to be aware of.